Gdansk, Poland

Sylwia Barańska

This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Instytut Farmaceutyczny. Active years: 2012-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sylwia Barańska. Retrieved from https://idiyas.com/inventor/sylwia-baranska

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 10.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Location History:

  • Gdańsk, PL (2012)
  • Gdansk, PL (2014)

Company Filing History:


Years Active: 2012-2014

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Sylwia Barańska: Innovator in Mucopolysaccharidosis Treatment

Introduction

Sylwia Barańska is a notable inventor based in Gdańsk, Poland. She has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mucopolysaccharidoses. With a total of 2 patents to her name, her work is paving the way for innovative therapeutic solutions.

Latest Patents

Barańska's latest patents focus on the use of isoflavones for treating mucopolysaccharidoses. One of her patents describes a method of treatment that includes administering a therapeutically effective amount of a natural isoflavone, a derivative, or a pharmaceutically acceptable salt to patients in need. The pharmaceutical composition also includes a suitable excipient, ensuring that the isoflavone is delivered effectively for the treatment of this condition.

Career Highlights

Throughout her career, Sylwia Barańska has worked with esteemed organizations such as the Pharmaceutical Institute and the University of Gdańsk. Her experience in these institutions has allowed her to develop her innovative ideas and contribute to the advancement of medical treatments.

Collaborations

Barańska has collaborated with notable colleagues, including Grzegorz Grynkiewicz and Grzegorz Wegrzyn. These partnerships have further enriched her research and development efforts in the pharmaceutical field.

Conclusion

Sylwia Barańska's work in the treatment of mucopolysaccharidoses through her innovative use of isoflavones showcases her dedication to advancing medical science. Her contributions are significant in the ongoing quest for effective therapies in this area.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…